We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMKR
2726
DELISTED
Emcore Corp
EMKR
| $353K | ﹤0.01% |
+3,831
| New | +$310K |
|
2727
Superior Group of Companies
SGC
$221M
| $349K | ﹤0.01% |
14,602
-1,371
| -9% | -$34.5K |
|
|
PRTK
2728
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $346K | ﹤0.01% |
50,736
-3,491
| -6% | -$28.2K |
|
2729
International Money Express
IMXI
$369M
| $345K | ﹤0.01% |
23,203
+406
| +2% | +$6.08K |
|
|
MCBC
2730
DELISTED
Macatawa Bank Corp
MCBC
| $345K | ﹤0.01% |
39,465
-4,424
| -10% | -$42.2K |
|
2731
Escalade
ESCA
$316M
| $344K | ﹤0.01% |
14,990
-3,136
| -17% | -$71.8K |
|
2732
KALA BIO
KALA
$14.1M
| $344K | ﹤0.01% |
26
+3
| +13% | +$47.2K |
|
|
DRRX
2733
DELISTED
DURECT Corp
DRRX
| $341K | ﹤0.01% |
20,911
-1,302
| -6% | -$22.7K |
|
2734
Stagwell
STGW
$2.26B
| $341K | ﹤0.01% |
+58,338
| New | +$272K |
|
|
VIRX
2735
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $341K | ﹤0.01% |
+30,082
| New | +$302K |
|
|
AKUS
2736
DELISTED
Akouos Inc
AKUS
| $340K | ﹤0.01% |
27,103
+6,574
| +32% | +$89.1K |
|
|
DZSI
2737
DELISTED
DZS Inc. Common Stock
DZSI
| $340K | ﹤0.01% |
16,393
-1,222
| -7% | -$21.2K |
|
2738
TherapeuticsMD
TXMD
$24.1M
| $339K | ﹤0.01% |
5,702
-690
| -11% | -$41.8K |
|
2739
XBiotech
XBIT
$69.5M
| $338K | ﹤0.01% |
20,385
-1,844
| -8% | -$31.3K |
|
2740
Ares Capital
ARCC
$14.2B
| $336K | ﹤0.01% |
17,153
-112
| -0.6% | -$2.17K |
|
2741
Kodak
KODK
$935M
| $335K | ﹤0.01% |
40,287
+18,122
| +82% | +$142K |
|
2742
CEL-SCI Corp
CVM
$28.7M
| $334K | ﹤0.01% |
1,284
-143
| -10% | -$88.5K |
|
2743
SIGA Technologies
SIGA
$224M
| $334K | ﹤0.01% |
53,139
-6,585
| -11% | -$45.2K |
|
|
GNOG
2744
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
| $334K | ﹤0.01% |
+26,187
| New | +$355K |
|
|
ESTE
2745
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $334K | ﹤0.01% |
30,164
-5,026
| -14% | -$45.6K |
|
2746
iShares Russell 2000 Growth ETF
IWO
$15B
| $333K | ﹤0.01% |
+1,067
| New | +$321K |
|
2747
MetroCity Bankshares
MCBS
$1.02B
| $333K | ﹤0.01% |
19,004
-2,866
| -13% | -$47.6K |
|
|
SURF
2748
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $332K | ﹤0.01% |
+44,438
| New | +$342K |
|
|
CMBM
2749
DELISTED
Cambium Networks
CMBM
| $331K | ﹤0.01% |
6,845
+1,414
| +26% | +$75.5K |
|
2750
Grid Dynamics Holdings
GDYN
$619M
| $331K | ﹤0.01% |
22,014
+3,496
| +19% | +$54.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.